A Qualitative Comparison of Symptoms and Impact of Varying Stages of Basal Cell Carcinoma

详细信息    查看全文

• 作者：Anna W. Steenrod ; Emily Nash Smyth ; Elizabeth N. Bush…
• 关键词：Basal cell carcinoma (BCC) ; Dermatology ; Health ; related quality of life (HRQL) ; Locally advanced ; Metastatic ; Non ; advanced BCC ; Non ; melanoma skin cancer (NMSC) ; Qualitative ; Symptomatology
• 刊名：Dermatology and Therapy
• 出版年：2015
• 出版时间：September 2015
• 年：2015
• 卷：5
• 期：3
• 页码：183-199
• 全文大小：506 KB
• 参考文献：1.Madan V, Lear JT, Szeimies RM. Non-melanoma skin cancer. Lancet. 2010;375:673-5.CrossRef PubMed
  2.Katalinic A, Kunze U, Schafer T. Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer). Br J Dermatol. 2003;149:1200-.CrossRef PubMed
  3.Staples MP, Elwood M, Burton RC, et al. Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust. 2006;184:6-0.PubMed
  4.Donaldson MR, Coldiron BM. No end in sight: the skin cancer epidemic continues. Semin Cutan Med Surg. 2011;30:3-.CrossRef PubMed
  5.Diffey BL, Langtry JA. Skin cancer incidence and the ageing population. Br J Dermatol. 2005;153:679-0.CrossRef PubMed
  6.Erba P, Farhadi J, Wettstein R, et al. Morphoeic basal cell carcinoma of the face. Scand J Plast Reconstr Surg Hand Surg. 2007;41:184-.CrossRef PubMed
  7.Miller SJ, Alam M, Andersen J, et al. Basal cell and squamous cell skin cancers. J Natl Compr Canc Netw. 2010;8:836-4.PubMed
  8.National Comprehensive Cancer Network. Basal and Squamous Cell Skin Cancer (Version 1.2014). http://?www.?nccn.?org/?professionals/?physician_?gls/?pdf/?nmsc.?pdf . Accessed July 13, 2015.
  9.Nunes DH, Frode TS. Quality of life in basal cell carcinoma patients in Brazil: a pilot cross sectional study. Dermatol Surg. 2013;39:620-.CrossRef PubMed
  10.Shingler SL, Garside J, Samanta K, et al. Utilities for advanced basal cell carcinoma. J Med Econ. 2013;16:777-3.CrossRef PubMed
  11.Caddick J, Green L, Stephenson J, Spyrou G. Psychological outcomes following surgical excision of facial skin cancers. Eur J Plast Surg. 2013;36:75-2.CrossRef
  12.Chren MM, Sahay AP, Bertenthal DS, et al. Quality-of-life outcomes of treatments for cutaneous basal cell carcinoma and squamous cell carcinoma. J Invest Dermatol. 2007;127:1351-.CrossRef PubMed
  13.Lee EH, Klassen AF, Nehal KS, et al. A systematic review of patient-reported outcome instruments of nonmelanoma skin cancer in the dermatologic population. J Am Acad Dermatol. 2013;69:e59-7.CrossRef PubMed
  14.Rhee JS, Matthews BA, Neuburg M, et al. Skin cancer and quality of life: assessment with the Dermatology Life Quality Index. Dermatol Surg. 2004;30:525-.PubMed
  15.Blackford S, Roberts D, Salek MS, Finlay A. Basal cell carcinomas cause little handicap. Qual Life Res. 1996;5:191-.CrossRef PubMed
  16.Lee KC, Weinstock MA, Veterans Affairs Topical Tretinoin Chemoprevention Trial G. Prospective quality of life impact of keratinocyte carcinomas: observations from the Veterans Affairs Topical Tretinoin Chemoprevention Trial. J Am Acad Dermatol. 2010;63:1107-.CrossRef PubMed
  17.Rhee JS, Matthews BA, Neuburg M, et al. Validation of a quality-of-life instrument for patients with nonmelanoma skin cancer. Arch Facial Plast Surg. 2006;8:314-.PubMed Central CrossRef PubMed
  18.Burdon-Jones D, Thomas P, Baker R. Quality of life issues in nonmetastatic skin cancer. Br J Dermatol. 2010;162:147-1.CrossRef PubMed
  19.Mathias SD, Chren MM, Colwell HH, et al. Assessing health-related quality of life for advanced basal cell carcinoma and basal cell carcinoma nevus syndrome: development of the first disease-specific patient-reported outcome questionnaires. JAMA Dermatol. 2014;150:169-6.CrossRef PubMed
  20.Edge S, Byrd DR, Compton CC, et al., editors. American Joint Committee on Cancer (AJCC) Cancer Staging Manual. 7th ed. New York: Springer; 2010.
  21.Patrick DL, Burke LB, Gwaltney CJ, et al. Content validity–establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1–eliciting concepts for a new PRO instrument. Value Health. 2011;14:967-7.CrossRef PubMed
  22.Hsieh H-F, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15:1277-8.CrossRef PubMed
  
• 作者单位：Anna W. Steenrod (1)
  Emily Nash Smyth (2)
  Elizabeth N. Bush (2)
  Anne Lynn S. Chang (4)
  Sarah T. Arron (5)
  Yolanda R. Helfrich (6)
  Daniel D. Von Hoff (7)
  Leslie H. Brail (2) (3)
  Karin S. Coyne (1)
  
  1. Evidera, Bethesda, MD, USA
  2. Early Phase Medical, Oncology, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA
  4. Stanford University, Stanford, CA, USA
  5. University of California San Francisco, San Francisco, CA, USA
  6. University of Michigan, Ann Arbor, MI, USA
  7. Translational Genomics Research Institute, HonorHealth, Phoenix and Scottsdale, Phoenix, AZ, USA
  3. Infinity Pharmaceuticals, Cambridge, MA, USA
  
• 刊物主题：Internal Medicine; Dermatology; Plastic Surgery; Oral and Maxillofacial Surgery; Quality of Life Research;
• 出版者：Springer Healthcare
• ISSN：2190-9172

文摘

Introduction Basal cell carcinoma (BCC) is the most common form of skin cancer; however, few data are available relating to patients-perspectives and experiences of this disease. This study explored the spectrum of BCC symptoms and their impact by disease stage to determine how BCC affects the overall health-related quality of life (HRQL) of patients.